Current diagnoses for Zika are made through molecular and serologic testing, and the CDC recommends both for infants who could be at risk. No commercial tests are available. CDC’s interim guidelines also include:
- How providers should report cases of infants carrying Zika to state and local health departments.
- Metrics for determining whether infants have microcephaly, a deformity in the size of the head linked to Zika that can cause severe developmental problems or death.
- How to manage care and treatment of infants who do not have microcephaly but whose mothers may have been infected with the virus at time of birth.
- Best practices for preventing mosquito bites for areas where active virus transmission is a risk.
More articles on infection control:
5 things to know about Zika
Search for better Zika diagnostics kicks into overdrive
Zika update: Spread warning, travel alerts, pregnancy recommendations
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
